Development and Validation of Human Psoriatic Skin Equivalents
- 30 September 2008
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 173 (3), 815-823
- https://doi.org/10.2353/ajpath.2008.080173
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- IL-22 is required for Th17 cell–mediated pathology in a mouse model of psoriasis-like skin inflammationJCI Insight, 2008
- Psoriasis is associated with increased β-defensin genomic copy numberNature Genetics, 2007
- Progress and opportunities for tissue-engineered skinNature, 2007
- Identification of avarol derivatives as potential antipsoriatic drugs using an in vitro model for keratinocyte growth and differentiationLife Sciences, 2006
- Sequence and Haplotype Analysis Supports HLA-C as the Psoriasis Susceptibility 1 GeneAmerican Journal of Human Genetics, 2006
- Psoriasis—recent advances in understanding its pathogenesis and treatmentJournal of the American Academy of Dermatology, 2005
- PsoriasisThe New England Journal of Medicine, 2005
- The Development and Characterization of an In Vitro Model of PsoriasisJournal of Investigative Dermatology, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Induction of normal and psoriatic phenotypes in submerged keratinocyte culturesJournal of Cellular Physiology, 1996